Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Clinical trial NCT01610414 · COMPLETED
Trial details
- NCT number
- NCT01610414
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-13
- Primary completion
- 2016-11-04
- Enrollment
- 1877
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.